7Baggers

Blend Labs Inc
(NYSE:BLND) 

BLND stock logo

Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journey...

Founded: 2012
Founder: Nima Ghamsari 
Sector: Technology
Industry:
TechnologySPAC
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                        
      revenue
    		             42,785,000 55,353,000 65,539,000 71,524,000 80,990,000 89,568,000 32,062,000 
      yoy
    		             -47.17% -38.20% 104.41%     
      qoq
    		             -22.71% -15.54% -8.37% -11.69% -9.58% 179.36%  
      software platform
    		27,993,000 30,336,000 30,459,000 29,391,000 24,260,000 27,637,000 31,066,000 26,475,000 21,736,000            
      professional services
    		2,850,000 2,096,000 2,401,000 2,132,000 2,510,000 2,485,000 2,038,000 2,221,000 2,104,000 2,258,000 2,137,000 2,216,000 1,734,000        
      total revenue
    		30,843,000 32,432,000 32,860,000 31,523,000 26,770,000 41,408,000 45,184,000 40,480,000 34,947,000 36,104,000 40,591,000 42,815,000 37,336,000        
      cost of revenue
    		             28,378,000 34,243,000 40,274,000 42,655,000 46,045,000 49,241,000 12,360,000 
      total cost of revenue
    		7,478,000 7,985,000 8,404,000 8,218,000 7,812,000 16,679,000 19,188,000 18,802,000 16,806,000 16,378,000 18,528,000 19,322,000 21,483,000        
      gross profit
    		23,365,000 24,447,000 24,456,000 23,305,000 18,958,000 24,729,000 25,996,000 21,678,000 18,141,000 19,726,000 22,063,000 23,493,000 15,853,000 14,407,000 21,110,000 25,265,000 28,869,000 34,945,000 40,327,000 19,702,000 
      yoy
    		23.25% -1.14% -5.92% 7.51% 4.50% 25.36% 17.83% -7.73% 14.43% 36.92% 4.51% -7.01% -45.09% -58.77% -47.65% 28.24%     
      qoq
    		-4.43% -0.04% 4.94% 22.93% -23.34% -4.87% 19.92% 19.50% -8.04% -10.59% -6.09% 48.19% 10.04% -31.75% -16.45% -12.48% -17.39% -13.35% 104.68%  
      gross margin %
    		Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% 33.67% 38.14% 38.55% 40.36% 43.15% 45.02% 61.45% 
      operating expenses:
    		                    
      research and development
    		9,413,000 9,468,000 8,522,000 7,332,000 7,520,000 8,861,000 10,127,000 12,916,000 14,183,000 14,417,000 18,826,000 22,091,000 26,257,000 33,248,000 34,240,000 35,500,000 35,106,000 28,740,000 25,518,000 20,884,000 
      sales and marketing
    		6,198,000 7,063,000 7,873,000 6,950,000 7,188,000 6,581,000 9,883,000 9,370,000 10,215,000 11,940,000 14,494,000 16,128,000 17,568,000 19,951,000 20,518,000 22,438,000 22,341,000 27,984,000 21,957,000 18,271,000 
      general and administrative
    		12,153,000 12,392,000 12,879,000 13,619,000 11,224,000 10,958,000 13,140,000 12,524,000 13,935,000 14,542,000 15,819,000 19,646,000 20,681,000 33,406,000 32,140,000 36,472,000 37,102,000 34,314,000 59,024,000 20,181,000 
      restructuring
    		662,000 31,000 93,000 28,000 719,000 116,000 6,165,000 207,000 983,000 694,000 9,122,000 2,349,000 12,783,000 2,959,000 5,936,000 6,380,000     
      total operating expenses
    		28,426,000 28,954,000 29,367,000 27,929,000 26,651,000 26,516,000 39,315,000 35,017,000 39,316,000 41,593,000 58,261,000 60,214,000 77,289,000 89,564,000 150,966,000 496,681,000 98,617,000 94,810,000 110,863,000 59,336,000 
      income from operations
    		-5,061,000 -4,507,000 -4,911,000 -4,624,000 -7,693,000 -1,787,000 -13,319,000 -13,339,000 -21,175,000 -21,867,000 -36,198,000 -36,721,000 -61,436,000 -75,157,000 -129,856,000 -471,416,000 -69,748,000 -59,865,000 -70,536,000 -39,634,000 
      yoy
    		-34.21% 152.21% -63.13% -65.33% -63.67% -91.83% -63.21% -63.67% -65.53% -70.90% -72.12% -92.21% -11.92% 25.54% 84.10% 1089.42%     
      qoq
    		12.29% -8.23% 6.21% -39.89% 330.50% -86.58% -0.15% -37.01% -3.16% -39.59% -1.42% -40.23% -18.26% -42.12% -72.45% 575.88% 16.51% -15.13% 77.97%  
      operating margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -175.66% -234.60% -719.29% -97.52% -73.92% -78.75% -123.62% 
      other income
    		40,000 1,377,000 17,348,000 1,018,000 1,114,000 1,105,000 10,710,000 -4,411,000 5,653,000 -1,498,000 2,632,000 3,232,000 2,882,000 1,538,000 3,281,000 6,000 91,000 110,000 121,000 112,000 
      income before income taxes
    		-5,021,000 -3,130,000 12,437,000 -3,606,000 -6,579,000 -682,000 -2,609,000 -19,398,000 -20,621,000 -30,450,000 -41,776,000 -41,436,000 -66,123,000 -80,967,000 -132,733,000 -477,136,000 -75,215,000 -65,419,000 -76,030,000 -39,522,000 
      income tax expense
    		-63,000 -151,000 -27,000 -41,000 -30,000 -20,750 -18,000 -23,000 -42,000            
      loss before equity in losses of equity method investees
    		-5,084,000                    
      equity in losses of equity method investees, net of tax
    		-381,000                    
      loss from continuing operations
    		-5,465,000   -3,647,000 -6,609,000                
      loss from discontinued operations
    		-2,584,000                    
      net income
    		-8,049,000 -3,458,000 12,532,000 -6,645,000 -9,412,000 -708,000 -2,627,000 -19,421,000 -20,663,000 -30,376,000 -41,820,000 -41,489,000 -66,194,000 -81,443,000 -132,747,000 -477,202,000 -72,418,000 -71,511,000 -76,330,000 5,766,000 
      yoy
    		-14.48% 388.42% -577.05% -65.78% -54.45% -97.67% -93.72% -53.19% -68.78% -62.70% -68.50% -91.31% -8.59% 13.89% 73.91% -8376.14%     
      qoq
    		132.76% -127.59% -288.59% -29.40% 1229.38% -73.05% -86.47% -6.01% -31.98% -27.36% 0.80% -37.32% -18.72% -38.65% -72.18% 558.95% 1.27% -6.31% -1423.79%  
      net income margin %
    		-Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -190.35% -239.82% -728.12% -101.25% -88.30% -85.22% 17.98% 
      less: net loss attributable to noncontrolling interest included in discontinued operations
    		    182,000                
      net loss attributable to blend labs, inc.
    		-8,049,000   -6,645,000 -9,230,000 -825,000 -2,445,000 -19,407,000 -20,668,000 -30,285,000 -41,760,000 -41,231,000 -65,417,000 -80,569,000 -126,128,000  -72,104,000 -71,687,000 -76,925,000  
      less: accretion of redeemable noncontrolling interest to redemption value from discontinued operations
    		    -1,254,000                
      less: accretion of series a redeemable convertible preferred stock to redemption value
    		-4,731,000 -4,696,000 -4,558,000 -4,376,000 -4,202,000 -4,170,000 -4,048,000 -2,661,000             
      net loss attributable to blend labs, inc. common stockholders
    		-12,780,000   -11,021,000 -14,686,000 -6,506,000 -8,253,000 -23,595,000 -22,129,000 -31,812,000 -43,212,000 -42,823,000 -67,473,000 -82,710,000 -133,975,000 -478,379,000 -73,546,000    
      net income per share
    		-0.05 -0.03 0.03                  
      continuing operations
    		-0.04 -0.03 0.03 -0.03 -0.04                
      discontinued operations
    		-0.01   -0.01 -0.01                
      weighted-average shares used for eps calculation
    		                    
      basic and diluted
    		255,630 258,949  259,211 258,832 253,921 254,910 253,069 250,932 245,206 246,410 244,262 241,444 234,161   230,329 131,985 200,176  
      comprehensive loss:
    		                    
      unrealized gain on marketable securities
    		-106  -62  6 -215 448 -42 -104 801 181 -773 821 -378 835 -502 -1,845   -6 
      foreign currency translation gain
    		172 42 103 -7 -43 52 13  9 42 106 -11 -18 75 55 77 28    
      comprehensive loss
    		-7,983   -6,696 -9,449 -871 -2,166 -19,463 -20,758 -29,533 -41,533 -42,273 -65,391 -79,991 -131,857  -74,235 -72,231 -76,422  
      less: comprehensive loss attributable to noncontrolling interest included in discontinued operations
    		    182                
      comprehensive loss attributable to blend labs, inc.
    		-7,983   -6,696 -9,267 -988 -1,984 -19,449 -20,763 -29,442 -41,473 -42,015 -64,614 -79,117 -125,238  -73,921 -72,407 -77,017  
      interest expense
    		       -1,648,000 -5,099,000 -7,085,000 -8,210,000 -7,947,000 -7,569,000 -7,348,000 -6,158,000 -5,726,000 -5,558,000 -5,664,000 -5,615,000  
      income from continuing operations
    		 538,500 12,410,000                  
      net income from discontinued operations
    		 -1,419,750 122,000  -2,803,000                
      net income attributable to blend labs, inc.
    		 -835,750 12,532,000             -441,371,000     
      net income attributable to blend labs, inc. common stockholders
    		 -4,433,250 7,974,000                  
      basic:
    		                    
      diluted:
    		                    
      weighted-average shares used for eps calculation
    		                    
      basic
    		  259,631            235,267 232,501    51,956 
      diluted
    		  268,719            235,267 232,501    77,864 
      comprehensive income:
    		                    
      comprehensive income
    		 -893 12,573             -477,627    5,760 
      comprehensive income attributable to blend labs, inc.
    		 -847.5 12,573             -441,796     
      net loss from discontinued operations
    		   -2,998,000                 
      unrealized loss on marketable securities
    		   -44              -20.75 -92  
      title
    		     11,286,000 12,080,000 11,784,000 11,107,000 10,232,000 11,949,000 12,484,000 12,632,000        
      less: net loss attributable to noncontrolling interest
    		     -117,000 182,000 14,000 -5,000 91,000 60,000 258,000 777,000 10,691,000 6,619,000 35,831,000 314,000    
      less: accretion of redeemable noncontrolling interest to redemption value
    		     -1,511,000 -1,760,000 -1,527,000 -1,461,000 -1,527,000 -1,452,000 -1,592,000 -2,056,000 -2,141,000 -7,847,000 -37,008,000 -1,442,000    
      net income per share
    		-0.05 -0.03 0.03                  
      basic and diluted
    		     -0.03 -0.03 -0.09 -0.09 -0.13 -0.18 -0.18 -0.28    -0.32 -0.31 -0.38  
      less: comprehensive loss attributable to noncontrolling interest
    		     -117 182 14 -5 91 60 258 777 874 6,619 35,831 314    
      software
    		         19,397,500 26,505,000 28,115,000 22,970,000        
      amortization of acquired intangible assets
    		              275,000 4,068,000 4,068,000 3,772,000 4,364,000  
      impairment of intangible assets and goodwill
    		              57,857,000 391,823,000     
      income tax benefit
    		         74,000 -44,000 -53,000 -71,000 -476,000 -14,000 -66,000 2,797,000 -6,092,000 -300,000 45,288,000 
      net income per share
    		-0.05 -0.03 0.03                  
      basic
    		             -0.738 -0.57 -2.06     
      diluted
    		             -0.738 -0.57 -2.06     
      less: undistributed earnings attributable to participating securities
    		                   -5,766,000 
      less: net income attributable to noncontrolling interest
    		                 -148,750 -595,000  
      less: comprehensive income attributable to noncontrolling interest
    		                 -176 -595  
      net income attributable to common stockholders
    		                    
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
                          
        assets
      		                    
        current assets:
      		                    
        cash and cash equivalents
      		37,430,000 43,578,000 55,021,000 36,499,000 56,244,000 42,243,000 55,041,000 45,450,000 84,521,000 30,962,000 84,555,000 34,980,000 46,195,000 124,199,000 114,380,000 132,683,000 167,666,000 213,082,000 276,063,000 369,726,000 
        marketable securities and other investments
      		21,607,000 24,739,000 22,234,000 51,801,000 48,574,000 56,233,000 61,744,000 67,153,000 43,504,000 105,960,000 160,406,000   229,948,000       
        trade and other receivables, net of allowance for credit losses of 79 and 112, respectively
      		17,880,000                    
        prepaid expenses and other current assets
      		16,183,000 15,121,000 20,105,000 17,128,000 15,916,000 19,329,000 13,722,000 10,315,000 13,321,000 14,569,000 18,645,000 22,423,000 23,405,000 19,231,000 25,445,000 21,938,000 27,825,000 31,713,000 37,264,000 27,062,000 
        current assets held for sale from discontinued operations
      		 5,640,000 6,427,000 6,440,000 8,518,000                
        total current assets
      		93,100,000 97,864,000 115,988,000 126,830,000 139,944,000 135,170,000 146,401,000 142,520,000 159,525,000 169,836,000 283,189,000 309,370,000 350,156,000 396,096,000 453,760,000 503,279,000 560,826,000 613,018,000 661,704,000 517,406,000 
        property and equipment
      		22,624,000 22,997,000 22,978,000 21,179,000 16,993,000 12,321,000 9,723,000 7,617,000 5,984,000 3,945,000 4,451,000 4,973,000 5,408,000 5,742,000 6,037,000 6,239,000 5,895,000 6,155,000 8,412,000 8,596,000 
        operating lease right-of-use assets
      		1,271,000 1,394,000 1,573,000 1,780,000 262,000 1,469,000 1,715,000 7,516,000 8,358,000 8,565,000 9,411,000 10,246,000 11,055,000 11,668,000 13,005,000 13,394,000 14,245,000 14,713,000 13,908,000 15,070,000 
        deferred contract costs
      		3,382,000 3,425,000 3,136,000 3,399,000 3,221,000 2,868,000 2,063,000 2,020,000 2,197,000 2,453,000 2,233,000 2,467,000 1,474,000 1,691,000 1,956,000 2,657,000 3,326,000 4,178,000 3,303,000 3,939,000 
        other non-current assets
      		40,882,000 41,425,000 42,559,000 25,938,000 21,930,000 24,103,000 16,848,000 16,344,000 16,299,000 11,867,000 9,662,000 9,006,000 9,868,000 10,082,000 10,521,000 8,129,000 8,617,000 8,828,000 8,530,000 14,196,000 
        non-current assets held for sale from discontinued operations
      		 2,940,000 3,263,000 3,873,000 5,839,000                
        total assets
      		161,259,000 170,045,000 189,566,000 183,072,000 188,266,000 178,012,000 186,129,000 185,410,000 201,760,000 206,065,000 318,354,000 350,496,000 385,442,000 432,764,000 492,768,000 599,324,000 1,054,430,000 1,112,486,000 1,178,226,000 1,043,537,000 
        liabilities, redeemable equity and stockholders’ equity
      		                    
        current liabilities:
      		                    
        accounts payable
      		259,000 1,826,000 772,000 1,201,000 2,666,000 2,417,000 1,863,000 1,084,000 1,898,000 2,170,000 2,121,000 3,149,000 1,932,000 1,260,000 2,550,000 3,302,000 2,116,000 6,160,000 6,809,000 6,273,000 
        deferred revenue
      		34,022,000 19,385,000 25,325,000 32,746,000 33,266,000 19,240,000 19,857,000 20,832,000 21,540,000 8,984,000 10,056,000 11,970,000 13,046,000 8,695,000 9,959,000 12,046,000 14,172,000 8,068,000 10,028,000 11,478,000 
        accrued compensation
      		3,988,000 4,555,000 4,596,000 2,854,000 3,901,000 3,976,000 6,046,000 3,225,000 5,186,000 5,562,000 9,867,000 4,741,000 11,035,000 10,059,000 13,753,000 9,576,000 13,489,000 18,140,000 13,397,000 13,819,000 
        other current liabilities
      		13,181,000 8,872,000 9,235,000 10,152,000 11,467,000 13,316,000 17,478,000 16,383,000 13,935,000 14,858,000 14,768,000 15,016,000 13,906,000 15,459,000 17,829,000 23,065,000 24,264,000 27,662,000 33,385,000 29,693,000 
        current liabilities held for sale from discontinued operations
      		 4,816,000 5,744,000 5,790,000 6,793,000                
        total current liabilities
      		51,450,000 39,454,000 45,672,000 52,743,000 58,093,000 38,949,000 45,244,000 41,524,000 42,559,000 31,574,000 36,812,000 34,876,000 39,919,000 35,473,000 44,091,000 47,989,000 54,041,000 60,030,000 63,619,000 256,840,000 
        other non-current liabilities
      		1,496,000 1,415,000 1,420,000 1,795,000 291,000 580,000 1,292,000 1,571,000 2,056,000 2,228,000 3,356,000 3,515,000 4,407,000 5,478,000 5,584,000 6,006,000 8,127,000 13,415,000 12,615,000  
        total liabilities
      		52,946,000 41,023,000 47,252,000 55,396,000 59,287,000 40,330,000 47,491,000 48,267,000 189,867,000 179,118,000 267,308,000 265,867,000 272,068,000 268,843,000 277,720,000 281,882,000 290,379,000 301,895,000 302,985,000 510,818,000 
        commitments and contingencies
      		                    
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of march 31, 2026 and december 31, 2025, 150 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
      		164,226,000                    
        stockholders’ equity:
      		                    
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of march 31, 2026 and december 31, 2025; 247,336 (class a 244,080, class b 3,256, class c 0) and 256,043 (class a 252,787, class b 3,256, class c 0) shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
      		2,000                    
        additional paid-in capital
      		1,343,247,000 1,360,704,000 1,375,276,000 1,377,769,000 1,376,752,000 1,328,015,000 1,333,781,000 1,335,928,000 1,326,187,000 1,321,944,000 1,318,037,000 1,311,539,000 1,299,603,000 1,286,815,000 1,260,092,000 1,238,476,000 1,244,466,000 1,218,213,000 1,199,914,000 77,661,000 
        accumulated other comprehensive income
      		663,000 597,000                  4,000 
        accumulated deficit
      		-1,399,825,000 -1,391,776,000 -1,388,318,000 -1,400,850,000 -1,394,205,000 -1,384,975,000 -1,384,150,000 -1,381,705,000 -1,362,298,000 -1,341,630,000 -1,311,345,000 -1,269,585,000 -1,228,354,000 -1,162,937,000 -1,082,368,000 -956,240,000 -514,869,000 -442,765,000 -371,078,000 -294,153,000 
        total stockholders’ equity
      		-55,913,000 -30,473,000 -12,485,000 -22,565,000 -16,886,000 -56,356,000 -49,602,000 -45,471,000 -35,763,000 -19,243,000 6,292,000 41,267,000 71,346,000 123,172,000 175,566,000 279,188,000 726,974,000 774,642,000 828,750,000 486,453,000 
        total liabilities, redeemable equity and stockholders’ equity
      		161,259,000 170,045,000 189,566,000 183,072,000 188,266,000 178,012,000 186,129,000 185,410,000             
        trade and other receivables, net of allowance for credit losses of 112 and 50, respectively
      		 8,786,000 12,201,000                  
        non-current liabilities held for sale from discontinued operations
      		 154,000 160,000 858,000 903,000                
        redeemable noncontrolling interest - held for sale from discontinued operations
      		                    
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of december 31, 2025 and 2024, 150 shares issued and outstanding as of december 31, 2025 and 2024, respectively
      		 159,495,000                   
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2025 and 2024; 256,043 (class a 252,787, class b 3,256, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of december 31, 2025 and 2024, respectively
      		 2,000                   
        intangible assets
      		  69,000 73,000 77,000 2,081,000 2,085,000 2,099,000 2,103,000 2,108,000 2,114,000 2,119,000 2,123,000 2,127,000 2,131,000 13,136,000 168,935,000 173,008,000 189,785,000 194,175,000 
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of september 30, 2025 and december 31, 2024, 150 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
      		  154,799,000                  
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of september 30, 2025 and december 31, 2024; 260,100 (class a 256,473, class b 3,627, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
      		  2,000                  
        accumulated other comprehensive loss
      		  555,000 514,000 565,000 602,000 765,000 304,000 346,000  -402,000 -689,000 95,000 -708,000 -2,160,000 -3,050,000 -2,625,000 -808,000 -88,000  
        trade and other receivables, net of allowance for credit losses of 99 and 50, respectively
      		   14,962,000                 
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of june 30, 2025 and december 31, 2024, 150 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
      		   150,241,000                 
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of june 30, 2025 and december 31, 2024; 260,051 (class a 256,424, class b 3,627, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
      		   2,000                 
        trade and other receivables, net of allowance for credit losses of 102 and 50, respectively
      		    10,692,000                
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of march 31, 2025 and december 31, 2024, 150 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively
      		    145,865,000                
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of march 31, 2025 and december 31, 2024; 258,825 (class a 255,078, class b 3,747, class c 0) and 258,173 (class a 254,426, class b 3,747, class c 0) shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively
      		    2,000                
        trade and other receivables, net of allowance for credit losses of 80 and 149, respectively
      		     17,365,000               
        operating lease liabilities, non-current
      		     801,000 955,000 5,172,000 6,398,000 6,982,000 8,135,000 9,236,000 10,236,000 11,091,000 12,090,000 12,654,000 13,684,000 14,607,000 13,589,000 14,555,000 
        debt, non-current
      		        138,854,000 138,334,000 219,005,000 218,240,000 217,506,000 216,801,000 215,955,000 215,233,000 214,527,000 213,843,000 213,162,000  
        redeemable noncontrolling interest
      		     52,375,000 50,747,000 49,169,000 47,656,000 46,190,000 44,754,000 43,362,000 42,028,000 40,749,000 39,482,000 38,254,000 37,077,000 35,949,000 46,491,000 46,266,000 
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of december 31, 2024 and 2023, 150 and 0 shares issued and outstanding as of december 31, 2024 and 2023, respectively
      		     141,663,000               
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2024 and 2023; 258,173 (class a 254,426, class b 3,747, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of december 31, 2024 and 2023, respectively
      		     2,000               
        trade and other receivables, net of allowance for credit losses of 76 and 149, respectively
      		      15,894,000              
        restricted cash, non-current
      		      7,294,000 7,294,000 7,294,000 7,291,000 7,294,000 12,315,000 5,358,000 5,358,000 5,358,000 5,358,000 5,358,000 5,358,000 5,607,000 5,357,000 
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized as of september 30, 2024 and december 31, 2023, 150 and 0 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively
      		      137,493,000              
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of september 30, 2024 and december 31, 2023; 255,881 (class a 252,134, class b 3,747, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively
      		      2,000              
        trade and other receivables, net of allowance for credit losses of 91 and 149, respectively
      		       19,602,000             
        series a redeemable convertible preferred stock, par value 0.00001 per share: 200,000 shares authorized, 150 and 0 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively
      		       133,445,000             
        class a, class b and class c common stock, par value 0.00001 per share: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 254,207 (class a 248,985, class b 5,222, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively
      		       2,000             
        trade and other receivables, net of allowance for credit losses of 128 and 149, respectively
      		        18,179,000            
        liabilities, redeemable noncontrolling interest and stockholders’ equity
      		                    
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2024 and december 31, 2023
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 252,319 (class a 242,769, class b 9,550, class c 0) and 249,910 (class a 240,262, class b 9,648, class c 0) shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively
      		        2,000            
        total liabilities, redeemable noncontrolling interest and stockholders’ equity
      		        201,760,000 206,065,000 318,354,000 350,496,000 385,442,000 432,764,000 492,768,000 599,324,000 1,054,430,000 1,112,486,000 1,178,226,000 1,043,537,000 
        trade and other receivables, net of allowance for credit losses of 149 and 436, respectively
      		         18,345,000           
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of december 31, 2023; no shares authorized, issued and outstanding as of december 31, 2022
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2023; 249,910 (class a 240,262, class b 9,648, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of december 31, 2023 and december 31, 2022, respectively
      		         2,000           
        accumulated other comprehensive gain
      		         441,000           
        trade and other receivables, net of allowance for credit losses of 198 and 436, respectively
      		          19,583,000          
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2023 and december 31, 2022
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 247,946 (class a 238,045, class b 9,901, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively
      		          2,000          
        marketable securities
      		           230,618,000 260,662,000  286,397,000 317,812,000 331,714,000 334,147,000 317,491,000 83,959,000 
        trade and other receivables, net of allowance for credit losses of 171 and 436, respectively
      		           21,349,000         
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of june 30, 2023 and december 31, 2022
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 245,775 (class a 235,606, class b 10,169, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively
      		           2,000         
        trade and other receivables, net of allowance for credit losses of 296 and 436, respectively
      		            19,894,000        
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2023 and december 31, 2022
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 243,607 (class a 233,056, class b 10,551, class c 0) and 240,931 (class a 230,210, class b 10,721, class c 0) shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively
      		            2,000        
        trade and other receivables, net of allowance for credit losses of 436 and 1,371, respectively
      		             22,718,000       
        goodwill
      		               47,132,000 287,228,000 287,228,000 286,977,000 284,798,000 
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of december 31, 2022; no shares authorized, issued and outstanding as of december 31, 2021.
      		                    
        class a, class, b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of december 31, 2022; 240,931 (class a 230,210, class b 10,721, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of december 31, 2022 and december 31, 2021, respectively
      		             2,000       
        trade and other receivables, net of allowance for credit losses of 670 and 1,371, respectively
      		              27,538,000      
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2022 and december 31, 2021
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 237,577 (class a 224,944, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of september 30, 2022 and december 31, 2021, respectively
      		              2,000      
        trade and other receivables, net of allowance for credit losses of 1,376 and 1,371, respectively
      		               30,846,000     
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of june 30, 2022 and december 31, 2021
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 234,795 (class a 222,162, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of june 30, 2022 and december 31, 2021, respectively
      		               2,000     
        trade and other receivables, net of allowance for credit losses of 1,669 and 1,371, respectively
      		                33,621,000    
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of march 31, 2022 and december 31, 2021
      		                    
        class a, class b and class c common stock, 0.00001 par value: 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized; 232,400 (class a 219,767, class b 12,633, class c 0) and 230,324 (class a 217,691, class b 12,633, class c 0) shares issued and outstanding as of march 31, 2022 and december 31, 2021, respectively
      		                2,000    
        trade and other receivables, net of allowance for credit losses of 1,371 and 0, respectively
      		                 34,076,000   
        restricted cash
      		                    
        founders convertible preferred stock and convertible preferred stock, 0.00001 par value: no shares authorized, issued and outstanding as of december 31, 2021; 128,123
      		                    
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of december 31, 2021; no shares authorized, issued and outstanding as of december 31, 2020.
      		                    
        class a, class, b and class c common stock, 0.00001 par value: 3,000,000
      		                 2,000 2,000  
        trade and other receivables
      		                  30,886,000 36,659,000 
        founders convertible preferred stock and convertible preferred stock, 0.00001 par value: no shares authorized, issued and outstanding as of september 30, 2021; 128,123
      		                    
        preferred stock, 0.00001 par value: 200,000 shares authorized and no shares issued and outstanding as of september 30, 2021; no shares authorized, issued and outstanding as of december 31, 2020.
      		                    
        acquisition consideration payable
      		                   195,577,000 
        other long-term liabilities
      		                   14,423,000 
        acquisition consideration expected to be funded from long-term debt proceeds
      		                   225,000,000 
        founders convertible preferred stock, 0.00001 par value: 1,026,008 shares authorized as of june 30, 2021 and december 31, 2020; 691,666 and 1,026,007 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively
      		                    
        convertible preferred stock, 0.00001 par value: 149,566,300 and 127,097,070 shares authorized as of june 30, 2021 and december 31, 2020, respectively; 146,180,902 and 121,352,684 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 710,477 and 387,841 as of june 30, 2021 and december 31, 2020, respectively
      		                   702,940,000 
        class a common stock
      		                    
        class b common stock
      		                   1,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                           
          operating activities
        		                   
          net loss
        		-8,049,000 -3,458,000 12,532,000 -6,645,000 -9,412,000 -708,000 -2,627,000 -19,421,000 -20,663,000 -30,376,000 -41,820,000 -41,489,000 -66,194,000 -81,443,000 -132,747,000 -477,202,000 -72,418,000 -71,511,000 -76,330,000 
          less: net loss from discontinued operations
        		-2,584,000 -177,000                  
          net loss from continuing operations
        		-5,465,000                   
          adjustments to reconcile net loss to net cash from operating activities:
        		                   
          stock-based compensation
        		6,780,000 7,579,000 7,766,000 7,562,000 6,048,000 6,064,000 6,671,000 7,271,000 8,071,000 6,223,000 9,042,000 14,364,000 16,392,000 28,191,000 27,951,000 29,248,000 24,312,000 16,795,000 43,424,000 
          depreciation and amortization
        		1,337,000 1,200,000 1,041,000 640,000 407,000 486,000 681,000 558,000 564,000 608,000 600,000 626,000 630,000 613,000 929,000 4,623,000 4,601,000 3,842,000 5,111,000 
          amortization of deferred contract costs
        		475,000 451,000 429,000 431,000 315,000 289,000 260,000 253,000 266,000 552,000 682,000 761,000 984,000 1,078,000 1,133,000 1,183,000 1,244,000 1,174,000 1,245,000 
          amortization of operating lease right-of-use assets
        		123,000 181,000 151,000 122,000 77,000 196,000 631,000 842,000 861,000 846,000 835,000 809,000 806,000 989,000 1,025,000 851,000 785,000 956,000 1,116,000 
          equity in losses of equity method investees, net of tax
        		381,000                   
          other
        		412,000 43,000 -39,000 -178,000 -138,000 -324,000 -359,000 -92,000 -234,000 -530,000 -1,285,000 -2,025,000 -1,347,000 169,000 501,000 410,000 1,049,000 1,628,000 487,000 
          changes in operating assets and liabilities:
        		                   
          trade and other receivables
        		-9,061,000 3,415,000 2,709,000 -4,270,000 3,906,000 -1,476,000 3,621,000 -1,409,000 182,000 1,245,000 1,709,000 -1,580,000 2,900,000 5,127,000 3,423,000 3,330,000 409,000 -3,778,000 -163,000 
          prepaid expenses and other assets, current and non-current
        		1,144,000 -721,000 -3,447,000 -1,651,000 389,000 -857,000 -3,656,000 2,486,000 967,000 3,544,000 2,415,000 1,058,000 -4,969,000 5,550,000 -4,173,000 5,167,000 2,830,000 4,257,000 -11,282,000 
          deferred contract costs, non-current
        		43,000 -289,000 263,000 -178,000 -353,000 -805,000 -43,000 177,000 256,000 -220,000 234,000 -993,000 217,000 265,000 701,000 669,000 852,000 -875,000 636,000 
          accounts payable
        		-1,599,000 1,054,000 -429,000 -1,465,000 1,046,000 554,000 868,000 -1,217,000 -272,000 49,000 -1,028,000 1,217,000 672,000 -1,290,000 -752,000 1,456,000 -4,314,000 -625,000 512,000 
          deferred revenue
        		14,637,000 -5,940,000 -7,421,000 -520,000 13,254,000 -617,000 -975,000 -708,000 12,556,000 -1,072,000 -1,914,000 -1,076,000 4,351,000 -1,264,000 -2,087,000 -2,126,000 6,104,000 -1,960,000 -1,450,000 
          accrued compensation
        		-543,000 -159,000 1,650,000 -1,195,000 511,000 -2,405,000 2,783,000 -1,961,000 -376,000 -4,305,000 5,126,000 -6,294,000 976,000 -3,694,000 4,177,000 -3,913,000 -4,651,000 4,638,000 -422,000 
          operating lease liabilities
        		-120,000 -136,000 -712,000 -974,000 -947,000 -1,393,000 -1,046,000 -1,096,000 -1,050,000 -1,068,000 -1,027,000 -914,000 -1,003,000 -1,225,000 -822,000 -883,000 -958,000 -1,049,000 -876,000 
          other liabilities, current and non-current
        		-82,000 -234,000 -524,000 31,000 2,179,000 -3,590,000 1,488,000 2,005,000 -1,099,000 -846,000 -246,000 387,000 -1,798,000 -1,270,000 -5,464,000 -2,125,000 -3,532,000 -4,522,000 6,029,000 
          net cash from operating activities - continuing operations
        		8,462,000 2,338,000 -2,733,000 -5,292,000 20,085,000               
          net cash from operating activities - discontinued operations
        		-1,110,000 -1,358,000 -757,000 -1,076,000 305,000               
          net cash from operating activities
        		7,352,000 980,000 -3,490,000 -6,368,000 20,390,000 -4,586,000 2,076,000 -6,666,000 -3,868,000 -20,691,000 -25,887,000 -34,390,000 -46,653,000 -47,333,000 -50,485,000 -46,758,000 -45,842,000 -43,124,000 -31,279,000 
          capital expenditures
        		142,000 -124,000 52,000 -327,000 528,000 -264,000 0 0 0 0 0 0 0 0 -446,000 -896,000 -268,000 -649,000 -560,000 
          free cash flows
        		7,494,000 856,000 -3,438,000 -6,695,000 20,918,000 -4,850,000 2,076,000 -6,666,000 -3,868,000 -20,691,000 -25,887,000 -34,390,000 -46,653,000 -47,333,000 -50,931,000 -47,654,000 -46,110,000 -43,773,000 -31,839,000 
          investing activities
        		                   
          purchases of marketable securities
        		-4,966,000 -4,995,000 -6,741,000 -11,873,000 -11,876,000 -5,608,000 -19,893,000 -28,217,000 -48,312,000 -32,798,000 -8,324,000 -8,751,000 -186,206,000 -49,325,000 -46,463,000 -19,305,000 -30,450,000 -34,764,000 -267,967,000 
          sale of available-for-sale securities
        		 0 19,968,000 11,000 848,000 0 30,000 0 100,297,000           
          maturities of marketable securities
        		8,000,000 2,500,000 16,500,000 8,800,000 18,927,000 11,300,000 26,250,000 5,000,000 10,600,000 32,595,000 80,146,000 40,139,000 157,570,000 107,164,000 78,096,000 31,741,000 30,035,000 16,393,000 33,850,000 
          additions to property, equipment and internal-use software development costs
        		-1,117,000 -1,001,000 -2,272,000 -3,733,000 -4,587,000 -2,581,000              
          net cash from investing activities - continuing operations
        		1,917,000 -1,241,000 27,455,000 -10,795,000 3,312,000               
          net cash from investing activities - discontinued operations
        		970,000 -13,000 -62,000 -36,000 -84,000               
          net cash from investing activities
        		2,887,000 -1,254,000   3,228,000 -1,889,000 11,747,000 -25,084,000 60,621,000 53,237,000 71,791,000 31,218,000 -28,940,000 57,387,000 31,187,000 11,540,000 -683,000 -19,172,000 -654,025,000 
          financing activities
        		                   
          proceeds from exercises of stock options, including early exercises, net of repurchases
        		96,000 147,000 712,000 430,000 363,000 789,000 155,000 95,000 619,000 248,000 -2,000 1,000 21,000 41,000 940,000 428,000 1,202,000   
          taxes paid related to net share settlement of equity awards
        		-1,127,000 -1,981,000 -1,886,000 -2,531,000 -2,971,000 -7,112,000 -3,984,000 -3,213,000 -3,806,000 -1,314,000 -1,325,000 -1,092,000 -2,440,000       
          share repurchases
        		-16,836,000 -15,727,000 -5,025,000 -1,550,000 -2,568,000               
          net cash from financing activities - continuing operations
        		-17,867,000 -17,561,000 -6,199,000 -3,651,000 -5,176,000               
          effect of exchange rates on cash, cash equivalents, and restricted cash
        		-5,000     0 0 -1,000 -4,000  -23,000 5,000 8,000  55,000 77,000 28,000   
          net increase in cash, cash equivalents, and restricted cash
        		-7,633,000 -17,835,000 17,704,000 -20,850,000 18,442,000 -12,798,000 9,591,000 -39,071,000 53,562,000     9,819,000 -18,303,000 -34,983,000 -45,416,000 -63,230,000 -93,413,000 
          cash, cash equivalents, and restricted cash at beginning of period
        		46,998,000 0 0 0 49,537,000 0 0 0 38,253,000 0 0 0 129,557,000 0 0 0 218,440,000 0 0 
          cash, cash equivalents, and restricted cash at end of period
        		39,365,000 -17,835,000 17,704,000 -20,850,000 67,979,000 -12,798,000 9,591,000 -39,071,000 91,815,000 -53,596,000 44,554,000 -4,258,000 51,553,000 9,819,000 -18,303,000 -34,983,000 173,024,000 -63,230,000 -93,413,000 
          less: cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations
        		 -1,369,000 -818,000 -1,105,000 6,712,000               
          cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations
        		39,365,000 -16,466,000 18,522,000 -19,745,000 61,267,000               
          reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets:
        		                   
          cash and cash equivalents
        		37,430,000 -11,443,000 18,522,000 -19,745,000 56,244,000 -12,798,000 9,591,000 -39,071,000 84,521,000 -53,593,000 49,575,000 -11,215,000 46,195,000 9,819,000 -18,303,000 -34,983,000 167,666,000 -62,981,000 -93,663,000 
          restricted cash
        		1,935,000  0 0 5,023,000 0 0 0 7,294,000 -3,000 -5,021,000 6,957,000 5,358,000 0 0 0 5,358,000 -249,000 250,000 
          total cash, cash equivalents, and restricted cash
        		39,365,000 -16,466,000 18,522,000 -19,745,000 61,267,000 -12,798,000 9,591,000 -39,071,000 91,815,000 -53,596,000 44,554,000 -4,258,000 51,553,000 9,819,000 -18,303,000 -34,983,000 173,024,000 -63,230,000 -93,413,000 
          supplemental disclosure of cash flow information:
        		                   
          cash paid for income taxes
        		  -132,000 199,000 133,000 0 0 67,000 9,000  0 -53,000 101,000    11,000 394,000 445,000 
          foreign
        		                   
          india
        		54,000                   
          supplemental disclosure of non-cash investing and financing activities:
        		                   
          reclassification of redeemable noncontrolling interest related to discontinued operations to equity
        		 0 0 0 52,675,000               
          stock-based compensation included in capitalized internal-use software development costs
        		119,000 225,000 592,000 1,127,000 1,218,000 509,000 811,000 494,000 636,000           
          accretion of redeemable noncontrolling interest related to discontinued operations to redemption value
        		 0 0 0 1,254,000               
          accretion of series a redeemable convertible preferred stock to redemption value
        		4,731,000 4,696,000 4,558,000 4,376,000 4,202,000 4,170,000 4,048,000             
          consideration receivable in connection with the sale of title assets
        		389,000                   
          capitalized internal-use software development costs included in accrued compensation
        		142,000 -124,000 52,000 -327,000 528,000 -264,000              
          amortization of debt discount and issuance costs
        		     0 0 170,000 520,000 689,000 790,000 759,000 730,000 871,000 747,000 731,000 709,000 706,000  
          accelerated amortization of right-of-use asset in connection with lease abandonment
        		     0              
          gain on conversion of note receivable to investment in equity securities
        		                   
          gain on investment in equity securities
        		 0    0 0 0 -4,417,000     0      
          loss on extinguishment of debt
        		     0 0             
          gain on sale of insurance business
        		     0              
          proceeds from sale of insurance business
        		     0              
          cash received in connection with conversion of note receivable to investment in equity securities
        		                   
          investment in non-marketable equity securities
        		 0 0               0  
          investment in note receivable
        		                 0  
          repayment of long-term debt
        		     0 0             
          net proceeds from the issuance of the series a redeemable convertible preferred stock and the haveli warrant
        		                   
          payment for issuance costs related to the series a redeemable convertible preferred stock and the haveli warrant
        		                   
          reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets:
        		                   
          state and local
        		                   
          texas
        		                   
          total income taxes paid
        		                   
          cash paid for interest
        		     0 0 1,621,000 4,529,000  7,364,000 7,189,000 6,911,000    4,944,000   
          conversion of note receivable to investment in equity securities
        		                   
          vesting of early exercised stock options
        		     0 7,000 172,000 184,000  230,000 256,000 758,000    1,913,000 1,677,000 1,809,000 
          operating lease liabilities arising from obtaining new or modified right-of-use assets
        		 -19,000 -56,000   0 497,000 0 654,000  0 0 327,000       
          covered warrant received in connection with strategic partnership and sale of insurance business
        		                   
          net income from continuing operations
        		                   
          accrual of transaction costs incurred in connection with sale of insurance business
        		                   
          less: net income from discontinued operations
        		   -2,998,000 -2,803,000               
          loss from continuing operations
        		   -3,647,000 -6,609,000               
          net cash provided (used in) by investing activities
        		                   
          issuance costs accrued in connection with the series a redeemable convertible preferred stock and the warrant
        		                   
          impairment of intangible assets and goodwill
        		             0 57,857,000     
          release of valuation allowance and change in deferred taxes
        		             0 0 0 -2,864,000 7,200,000 0 
          proceeds from initial public offering, net of underwriters' fees and issuance costs
        		             0    -2,048,000  
          net cash from financing activities
        		     -6,323,000 -4,232,000 -7,320,000 -3,187,000 -86,121,000 -1,327,000 -1,091,000 -2,419,000 41,000 940,000 158,000 1,081,000 -925,000 591,891,000 
          accretion of redeemable noncontrolling interest to redemption value
        		     1,511,000 1,760,000 1,527,000 1,461,000  1,452,000 1,592,000 2,056,000    1,442,000   
          net proceeds from the issuance of the series a redeemable convertible preferred stock and the warrant
        		      0             
          payment for issuance costs related to the series a redeemable convertible preferred stock and the warrant
        		      -403,000             
          warrant received in connection with strategic partnership and sale of insurance business
        		                   
          additions to property, equipment, internal-use software development costs and intangible assets
        		       -1,867,000 -1,964,000           
          sale of marketable securities
        		                   
          additions to property, equipment, internal-use software and intangible assets
        		         -82,000 -31,000 -170,000 -304,000       
          acquisition of title365, net of cash acquired
        		                 0  
          proceeds from debt financing, net of issuance costs
        		                 -24,000  
          partial repayment of long-term debt principal
        		                   
          proceeds from issuance of convertible preferred stock, net of issuance costs
        		                 0 0 
          proceeds from exercises of convertible preferred stock warrants
        		                 0 0 
          proceeds from repayment of employee promissory note collateralized by common stock
        		                 0  
          effect of exchange rates on cash, cash equivalents and restricted cash
        		                   
          payment of initial public offering costs
        		               -270,000 -121,000   
          net decrease in cash, cash equivalents, and restricted cash
        		          44,554,000 -4,258,000 -78,004,000       
          sales of marketable securities
        		                   
          proceeds from exercises of common stock warrants
        		                   
          purchases of property and equipment
        		              -446,000 -896,000 -268,000 -649,000 -560,000 
          purchase of other investment
        		                   
          cash acquired in connection with business combination
        		                   
          payment of debt issuance costs
        		                   
          right-of-use assets obtained in exchange for lease obligations
        		                317,000   
          interest on discount on convertible note
        		                   
          capitalization of internal-use software
        		                   
          purchases of intangible assets
        		                   
          repurchases of unvested early exercised stock options
        		                 -110,000 -10,000 
          proceeds from exercises of stock options, including early exercises
        		                 1,257,000 708,000 
          proceeds from convertible debt
        		                   
          proceeds from exercises of series d convertible preferred stock warrants
        		                   
          non-cash additions to property and equipment
        		                   
          issuance of warrant in connection with debt financing
        		                 0  
          exercise of series d convertible preferred stock warrants included in prepaid expenses and other current assets
        		                   
          deferred offering costs not yet paid
        		                  -2,661,000 
          payment of deferred offering costs
        		                   
          repayment of employee promissory note collateralized by common stock
        		                   
          acquisition cash consideration not yet paid
        		                   
          additions of property and equipment included in accrued expenses